• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅰ-Ⅱ期原发性皮肤恶性黑色素瘤患者的条件无复发生存率——一项基于人群的研究

Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.

作者信息

Lyth Johan

机构信息

Research and Development Unit in Region Östergötland, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

出版信息

Melanoma Res. 2018 Dec;28(6):637-640. doi: 10.1097/CMR.0000000000000479.

DOI:10.1097/CMR.0000000000000479
PMID:29994850
Abstract

Conditional survival in patients with localized primary cutaneous malignant melanoma (CMM) is well described. However, conditional recurrence-free survival (RFS) has not been investigated before. The aim of this study was to determine conditional RFS and test for time dependency in prognostic factors in patients with localized stage I-II CMM. This study included 1437 CMM patients registered in one region of Sweden during 1999-2012 followed up through 31 December 2012. To identify first recurrence of CMM disease, data from a care data warehouse, the pathology and radiology department registries were used. Patients were also followed through a Census Register and the National Cause of Death Register. The time-dependent risk of recurrence was analysed in a Cox's proportional hazard regression. The 5-year conditional RFS increased from 86% (95% confidence interval: 84-88) at diagnosis to 96% (95% confidence interval: 94-98) at 5 years after diagnosis. Women showed a 60% lower risk of recurrence than men and this effect was stable over time (P=0.39). Patients aged greater than or equal to 65 years had a 40% higher risk of recurrence than patients aged less than 65 years, and this effect was stable over time (P=0.65). Patients with tumour ulceration showed a 70% higher risk of recurrence than nonulcerated patients, but this effect disappeared after 2 years (P=0.04). For patients with T3-T4 CMM, the hazard ratios decreased over time and were similar to hazard ratio of patients with T2 CMM after 2 years and later. The decreasing impact of tumour thickness and ulceration over time could have important implications for CMM patients in terms of counselling and follow-up.

摘要

局限性原发性皮肤恶性黑色素瘤(CMM)患者的条件生存情况已有详尽描述。然而,此前尚未对条件无复发生存期(RFS)进行过研究。本研究的目的是确定局限性Ⅰ - Ⅱ期CMM患者的条件RFS,并检验预后因素的时间依赖性。本研究纳入了1999年至2012年期间在瑞典一个地区登记的1437例CMM患者,随访至2012年12月31日。为确定CMM疾病的首次复发情况,使用了来自医疗数据仓库、病理和放射科登记处的数据。患者还通过人口普查登记册和国家死亡原因登记册进行随访。在Cox比例风险回归中分析复发的时间依赖性风险。5年条件RFS从诊断时的86%(95%置信区间:84 - 88)增加到诊断后5年的96%(95%置信区间:94 - 98)。女性复发风险比男性低60%,且这种效应随时间稳定(P = 0.39)。年龄大于或等于65岁的患者复发风险比年龄小于65岁的患者高40%,且这种效应随时间稳定(P = 0.65)。有肿瘤溃疡的患者复发风险比无溃疡患者高70%,但这种效应在2年后消失(P = 0.04)。对于T3 - T4期CMM患者,风险比随时间下降,2年后及以后与T2期CMM患者的风险比相似。肿瘤厚度和溃疡随时间影响的降低对于CMM患者的咨询和随访可能具有重要意义。

相似文献

1
Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.Ⅰ-Ⅱ期原发性皮肤恶性黑色素瘤患者的条件无复发生存率——一项基于人群的研究
Melanoma Res. 2018 Dec;28(6):637-640. doi: 10.1097/CMR.0000000000000479.
2
Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.原发性 I-II 期皮肤恶性黑色素瘤患者首次复发的预后危险因素——基于人群的瑞典黑色素瘤登记处。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1468-1474. doi: 10.1111/jdv.14280. Epub 2017 May 9.
3
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.独居男性诊断时处于晚期且生存更差:来自瑞典的全国性基于人群的研究。
J Clin Oncol. 2014 May 1;32(13):1356-64. doi: 10.1200/JCO.2013.52.7564. Epub 2014 Mar 31.
4
Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.黑色素瘤患者生存结局的预后工具:基于瑞典全国性黑色素瘤登记处的数据。
Eur J Cancer. 2016 May;59:171-178. doi: 10.1016/j.ejca.2016.02.029. Epub 2016 Apr 2.
5
Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.多原发皮肤恶性黑色素瘤诊断后疾病特异性生存率降低:一项全国性、基于人群的研究。
Int J Cancer. 2017 Dec 1;141(11):2243-2252. doi: 10.1002/ijc.30925. Epub 2017 Aug 24.
6
Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.瑞典皮肤恶性黑色素瘤确诊移民的预后因素及疾病特异性生存率
Int J Cancer. 2016 Aug 1;139(3):543-53. doi: 10.1002/ijc.30103. Epub 2016 Apr 19.
7
Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.瑞典 1997-2011 年皮肤恶性黑色素瘤的趋势:男性肿瘤变薄,存活率提高。
Br J Dermatol. 2015 Mar;172(3):700-6. doi: 10.1111/bjd.13483. Epub 2015 Feb 5.
8
Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.低教育水平与皮肤恶性黑色素瘤诊断时的晚期和生存率降低有关:瑞典一项全国性基于人群的研究。
Eur J Cancer. 2013 Aug;49(12):2705-16. doi: 10.1016/j.ejca.2013.03.013. Epub 2013 Apr 11.
9
Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.局限性浸润性原发性皮肤恶性黑色素瘤的预后因素:一项大型基于人群的研究结果。
Br J Dermatol. 2015 Jan;172(1):175-86. doi: 10.1111/bjd.13171. Epub 2014 Nov 27.
10
Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations.原发部位对皮肤恶性黑色素瘤患者预后的影响。一项使用新模型分析解剖位置的研究。
Melanoma Res. 2005 Apr;15(2):125-32. doi: 10.1097/00008390-200504000-00007.

引用本文的文献

1
Temporal Recurrence of Cutaneous Melanoma: Analysis of a Case Series.皮肤黑色素瘤的颞部复发:一组病例分析
J Clin Aesthet Dermatol. 2023 Dec;16(12):32-38.
2
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study.血清标志物可改善早期黑色素瘤患者转移发展的当前预测:基于机器学习的研究。
Mol Oncol. 2020 Aug;14(8):1705-1718. doi: 10.1002/1878-0261.12732. Epub 2020 Jun 24.